Trading in Novo Nordisk shares by board members, executives and associated persons on 3 November 2020

November 3, 2020 Off By GlobeNewswire

Bagsværd, Denmark, 3 November 2020 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.

Further information

Media:    
Mette Kruse Danielsen +45 4442 3883 [email protected]
Ken Inchausti (US) +1 609 240 9429 [email protected]
     
Investors:    
Daniel Muusmann Bohsen +45 3075 2175 [email protected]
Valdemar Borum Svarrer +45 3079 0301 [email protected]
Ann Søndermølle Rendbæk +45 3075 2253 [email protected]
Mark Joseph Root +45 3079 4211 [email protected]
Kristoffer Due Berg US) +1 609 235 2989 [email protected]

Company announcement No 66 / 2020

Attachment